Evidence map›Paper›PMID 39113782›Full record

ArticleWiley interdisciplinary reviews. Computational statistics

Biomarker data with measurement error in medical research: A literature review.

Ching-Yun Wang, Wen-Han Hwang, Xiao Song

Abstract read
In one paragraph

Article in Wiley interdisciplinary reviews. Computational statistics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ching-Yun WangDivision of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington, USA.ORCID 0000-0002-1883-333X
Wen-Han HwangInstitute of Statistics, National Tsing-Hua University, Hsinchu, Taiwan.
Xiao SongDepartment of Epidemiology and Biostatistics, College of Public Health, University of Georgia, Athens, Georgia, USA.

Funding

Statistical methods for analyzing objectively measured physical activity dataR01HL130483 · NHLBI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Chongzhi Di · 2016 to 2026
$4.4M
SCH: Novel and Interpretable Statistical Learning for Brain Images in AD/ADRDsR01AG085616 · NIA · GEORGE MASON UNIVERSITY · PI XIAO SONG, GuanNan Wang · 2023 to 2026
$1.1M
Methods for Measurement Error in Physical Activity & Diet DataR21HL121347 · NHLBI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI WANG, CHING-YUN · 2014 to 2015
$491k
Joint Modeling of Longitudinal Physical Activity and Diet Data and SurvivalR21CA239168 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI WANG, CHING-YUN · 2020 to 2021
$464k
A novel approach to pinpoint predisposed recombination regions in HIV for a global profile of HIV recombinants' occurrence and evolutionR21AI176947 · NIAID · UNIVERSITY OF GEORGIA · PI HUANG, HANWEN, SONG, XIAO · 2023 to 2024
$386k
Predictive cancer biomarkers: Design and analysis of reproducibility studiesR21CA201207 · NCI · UNIVERSITY OF GEORGIA · PI DOBBIN, KEVIN K, SONG, XIAO · 2016 to 2017
$359k
Novel Methods for Missing Subtype Data in Colorectal CancerR03CA235122 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI WANG, CHING-YUN · 2019 to 2020
$176k
NCI NIH HHS R03 CA235122NCI NIH HHS R21 CA201207NCI NIH HHS R21 CA239168NHLBI NIH HHS R01 HL130483NHLBI NIH HHS R21 HL121347NIAID NIH HHS R21 AI176947NIA NIH HHS R01 AG085616
6 · The paper itself

Abstract

A biomarker is a measurable indicator of the severity or presence of a disease or medical condition in biomedical or epidemiological research. Biomarkers may help in early diagnosis and prevention of diseases. Several biomarkers have been identified for many diseases such as carbohydrate antigen 19-9 for pancreatic cancer. However, biomarkers may be measured with errors due to many reasons such as specimen collection or day-to-day within-subject variability of the biomarker, among others. Measurement error in the biomarker leads to bias in the regression parameter estimation for the association of the biomarker with disease in epidemiological studies. In addition, measurement error in the biomarkers may affect standard diagnostic measures to evaluate the performance of biomarkers such as the receiver operating characteristic (ROC) curve, area under the ROC curve, sensitivity, and specificity. Measurement error may also have an effect on how to combine multiple cancer biomarkers as a composite predictor for disease diagnosis. In follow-up studies, biomarkers are often collected intermittently at examination times, which may be sparse and typically biomarkers are not observed at the event times. Joint modeling of longitudinal and time-to-event data is a valid approach to account for measurement error in the analysis of repeatedly measured biomarkers and time-to-event outcomes. In this article, we provide a literature review on existing methods to correct for estimation in regression analysis, diagnostic measures, and joint modeling of longitudinal biomarkers and survival outcomes when the biomarkers are measured with errors. This article is categorized under: Statistical and Graphical Methods of Data Analysis > Robust MethodsStatistical and Graphical Methods of Data Analysis > EM AlgorithmStatistical Models > Survival Models.

Indexed as

longitudinal datameasurement errorsurrogatesurvival analysis

Identifiers

PMID39113782
PMCPMC11305697

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.